A single intravenous dose of the
osteoporosis drug zoledronic acid improved bone mineral density in a group of frail elderly women living in nursing homes and long - term - care facilities, according to an article published online by JAMA Internal
Medicine.
In a related commentary, Robert Lindsay, M.B., Ch.B., Ph.D., of Helen Hayes Hospital, West Haverstraw, N.Y., writes: «In this issue of JAMA Internal
Medicine, Greenspan and colleague present intriguing data on zoledronic acid, one of the most potent
drugs in the bisphosphonate family — if not the most potent — approved for treatment of
osteoporosis.»
Tags: Adjustment Bone Density Chiropractic Chiropractic Research Diet
Drugs Exercise Fitness Healing Healthy Bone Innate Intelligence Lifestyle Lifestyle
Medicine Nervous system nutrition
Osteoporosis Prevention Research Vitamin D